Our News / Press Release

NEW INVESTMENT AND STRATEGIC STEP: TFLL Pharma is now a 100% Belgian company

NEW INVESTMENT AND STRATEGIC STEP: TFLL Pharma is now a 100% Belgian company


NEW INVESTMENT AND STRATEGIC STEP:

TFLL Pharma is now a 100% Belgian company

[Belgium, September 2025]

 

TFLL Pharma has reached a significant milestone in its journey in human health and longevity. With a new investment round, 25% of the company’s shares have been acquired by investors, while the remaining 75% is held by CEO Serhan Şimşek. As of September 2025, TFLL Pharma has officially become a 100% Belgian company.

 

With this new investment, TFLL Pharma aims to strengthen its activities and expand its product portfolio in both food supplements and research peptides, operating actively in Turkey as well as across Europe.

 

Vision and Strategic Goals

Founded in 2017 by CT Pharma Research, TFLL Pharma has been committed to developing innovative solutions that target the body’s natural defense systems under its vision “Thinking Future Long Life.” Based in the Flemish region of Belgium at the Bioville Science Park, the company plans to further expand its R&D-driven structure with this investment.

 

Expanding Product Portfolio

TFLL Pharma currently develops special food supplements under the Custom Supplements® brand and recently began producing research peptides in Belgium, including: Epitalon, MOTS-C, BPC-157, TB-500, GHK-Cu, Ipamorelin, CJC-1295.

These products address the needs of both scientific communities and consumers. With the new investment, TFLL Pharma will accelerate development and expand into global markets.

 

Message from the CEO

“Becoming a 100% Belgian company is a strong step in our international growth strategy. With this new investment, we will continue to expand our R&D efforts and develop innovative products in food supplements and research peptides, both in Turkey and across Europe.”
– Şerhan Şimşek, PhD – CEO, TFLL Pharma

 

For more information about TFLL Pharma, please visit  www.tfllpharma.com

 

 TFLL Pharma

Contact: Serhan Şimşek, PhD – CEO

Phone:

+90 216 687 09 53

+32 11 286 900

E-mail: info@tfllpharma.com

Website: www.tfllpharma.com